Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Long-term vitamin C supplementation has no markedly favourable effect on serum lipids in middle-aged Japanese subjects
2004
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis
2007
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)
2010
The role of B cells in atherosclerosis
2018
Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
2009
Drug Treatment of Hyperlipidemia in Women
2004
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Innate Immune Receptors: Key Regulators of Metabolic Disease Progression
2013
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
2009
The role of vitamin E in atherosclerosis
2003
The gut microbiota and its relationship to diet and obesity
2012
Human Genetics Shape the Gut Microbiome
2014 Standout
Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin
2004
Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
2005
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush
2006
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
2007
Mechanism of Action of Niacin
2008
The metabolic syndrome
2010 Standout
High-Density Lipoprotein as a Therapeutic Target
2007
Hallmarks of aging: An expanding universe
2023 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin
2003
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
2020
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials
2003
Genetically Programmed Biases in Th1 and Th2 Immune Responses Modulate Atherogenesis
2008
The changing landscape of atherosclerosis
2021 StandoutNature
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial
2003
Regulation of Serum Amyloid A3 (SAA3) in Mouse Colonic Epithelium and Adipose Tissue by the Intestinal Microbiota
2009
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Patterns of oxidized epitopes, but not NF-κB expression, change during atherogenesis in WHHL rabbits
2002
Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)
2007
Characteristics of US adults with the metabolic syndrome and therapeutic implications
2004
Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production
2004
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease
2008
Myocardial infarction and third generation oral contraceptives: aggregation of recent studies
2002
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Vitamins E and C in the Prevention of Cardiovascular Disease in Men
2008
Combined therapy in the treatment of dyslipidemia
2009
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Update on strategies to increase HDL quantity and function
2009
Beyond High-Density Lipoprotein Cholesterol Levels
2008
Antioxidants: The good, the bad and the ugly
2006
Lipoprotein Management in Patients With Cardiometabolic Risk
2008
Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat diet
2015
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety
2007
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
2015 StandoutNature
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans
2008
Women's Angiographic Vitamin and Estrogen trial:
2002
NAD+ homeostasis in health and disease
2020
Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia
2008
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
The SU.VI.MAX Study
2004
Comparison of Once-Daily, niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])
2003
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
2012
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
2004 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
2001
What We Talk About When We Talk About Fat
2014 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
2009
Safety of Aggressive Lipid Management
2007
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Nicotinic Acid-Induced Flushing Is Mediated by Activation of Epidermal Langerhans Cells
2006
Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
2004
Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory?
2005
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions
2000
Safety Considerations with Niacin Therapy
2006
Hepatocellular Carcinoma
2011 Standout
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in Women
2007
Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women
2002
The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers
2006
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue
2010
Can antioxidant vitamins materially reduce oxidative damage in humans?
1999
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes
2003
A review of the epidemiological evidence for the ‘antioxidant hypothesis’
2004
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
The Effect of Vitamin E on Endothelial Function of Micro- and Macrocirculation and Left Ventricular Function in Type 1 and Type 2 Diabetic Patients
2005
Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins
2007
Clinical trials report
2002
Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer
2005
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations 1–3
2006
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression
2003
Statins in Stroke Prevention and Carotid Atherosclerosis
2004
Inflammasomes and Metabolic Disease
2013
Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection
2014
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Ascorbic Acid Reduces Blood Pressure and Arterial Stiffness in Type 2 Diabetes
2002
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004
Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?
2002
Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes
2002
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers
2006
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis
2002
Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans
2004
Works of Shari Wang being referenced
Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation
2016
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
2011
Serum amyloid A3 does not contribute to circulating SAA levels
2009
T Cell Activation Inhibitors Reduce CD8+ T Cell and Pro-Inflammatory Macrophage Accumulation in Adipose Tissue of Obese Mice
2013
Deletion of Serum Amyloid A3 Improves High Fat High Sucrose Diet-Induced Adipose Tissue Inflammation and Hyperlipidemia in Female Mice
2014
Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
2001
Toll-Like Receptor 4 Deficiency Decreases Atherosclerosis But Does Not Protect Against Inflammation in Obese Low-Density Lipoprotein Receptor–Deficient Mice
2012
Serum amyloid A impairs the antiinflammatory properties of HDL
2015
Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice
2004
Oxidation-Specific Epitopes in Human Coronary Atherosclerosis Are Not Limited to Oxidized Low-Density Lipoprotein
1996